Xenitra's latest quarterly report outlines continued growth across its health and wellness business. This episode covers revenue performance, cash flow, progress with the OPAL platform, developments across its OTC medicines and nutritionals divisions, corporate updates, and the company's priorities for the year ahead.

Xenitra Limited (ASX:XEN) | Quarterly Activities/Appendix 4C Cash Flow Report

Trading Titan breaks down ASX announcements one company at a time, several times a day.Each episode takes a single announcement and answers three things: what was announced, what it lets the company do, and what it means if you're thinking about investing.The goal is simple — surface announcements you might have missed, and tell you why they matter before the market has fully worked it out.

Business

News

Trading Titan breaks down ASX announcements one company at a time, several times a day. Each episode takes a single announcement and answers three things: what was announced, what it lets the company do, and what it means if you're thinking about investing. The goal is simple — surface announcements you might have missed, and tell you why they matter before the market has fully worked it out.

Share Xenitra Limited (ASX:XEN) | Quarterly Activities/Appendix 4C Cash Flow Report

Sign up to save your podcasts

Xenitra Limited (ASX:XEN) | Quarterly Activities/Appendix 4C Cash Flow Report

Xenitra Limited (ASX:XEN) | Quarterly Activities/Appendix 4C Cash Flow Report